EZH2 and hepatocellular carcinoma: Enhancers of zeste homologue 2 (EZH2), AT-rich interaction domain 1A (ARID1A), and AT-rich interactive domain 2 (ARID2) are three prominent and well-studied chromatin modifiers involved in HCC pathogenesis.